project |
|
|---|---|
|
Name/scientific name |
PORACTANT ALFA
|
|
Self-financed or subsidized by the Hospital Authority |
Hospital Authority Drug Formulary
|
|
Indications |
respiratory distress syndrome, respiratory insufficiency
|
|
body system |
respiratory system
|
|
type |
Antihistamines and emergency allergies
|
PORACTANT ALFA is a medicine used to treat adult respiratory distress syndrome (ARDS) in premature infants. It is a synthetic pulmonary surfactant that helps improve breathing difficulties and improve lung function. PORACTANT ALFA is typically injected directly into the patient's lungs through an endotracheal tube to help reduce surface tension in the lungs, prevent alveolar collapse, and promote gas exchange.
When using PORACTANT ALFA, medical staff should strictly follow the instructions of the doctor and the instructions for use. Patients may experience side effects including difficulty breathing, airway spasms, or decreased oxygen saturation. If any unusual symptoms occur, notify your doctor immediately.
Overall, PORACTANT ALFA is an effective treatment that can help improve lung function in patients with respiratory distress syndrome. During use, pay close attention to patient reactions and follow the advice of medical professionals.
HOW TO USE: PORACTANT ALFA is a pulmonary surfactant indicated for the treatment of neonatal respiratory distress syndrome. The drug should be injected directly into the patient's lungs through the endotracheal tube. Before use, make sure the patient's endotracheal tube is in the correct position. PORACTANT ALFA is usually administered to newborns shortly after birth and should be administered by a health care provider in an appropriate medical setting.
Dosage Guidelines: Dosage of PORACTANT ALFA is based on patient weight. For neonates, a starting dose of 2.5 ml/kg is usually recommended and adjusted as needed. Dosage may vary based on the patient's age and condition. When using PORACTANT ALFA, healthcare professionals should determine the most appropriate dose based on the patient's specific condition and closely monitor the patient's response to make necessary adjustments. For pediatric patients, the dose may need to be adjusted based on their age and weight, and medical staff should strictly follow the recommendations of medical experts for dose management.
PORACTANT ALFA is a drug used to treat respiratory distress in premature infants. Side effects include difficulty breathing, respiratory infections, too much oxygen, pulmonary bleeding, and fast or slow heartbeats. Some patients may also develop digestive system problems such as fever, sore throat, vomiting, and diarrhea. When using PORACTANT ALFA, pay close attention to your baby's condition and report any abnormalities to your doctor at any time. If you notice serious side effects, seek medical advice immediately.
PORACTANT ALFA is a drug used to treat respiratory distress syndrome in premature infants. However, the following contraindications should be noted when using PORACTANT ALFA:
1. Patients who are allergic to PORACTANT ALFA or any of its ingredients should not use this drug as it may cause severe allergic reactions.
2. It is not recommended to use PORACTANT ALFA in premature infants whose birth weight is less than 700 grams, because the safety and effectiveness have not been established.
3. Premature infants with birth defects or congenital abnormalities should use PORACTANT ALFA with caution and under the guidance of a physician.
Before using PORACTANT ALFA, patients should inform their physician about allergic reactions, existing medical conditions, and other medications being used to ensure safe use. Patients should inform their medical professional immediately if they experience any unusual symptoms or reactions. Use PORACTANT ALFA as recommended and prescribed by your physician to ensure therapeutic effectiveness and safety.
No valid response from GPT API
We are the first medical service company in Hong Kong that can complete appointment, communication and payment all through mobile phones. You can easily make an appointment for nursing services through your mobile phone in as little as 3 minutes. The whole process can be done by mobile phone. There is no need to make phone calls and wait for an agency to respond to the selection of medical staff.
traditional care agency
careEASY
Registered Nurse (12 hours)
$3300
$2900(-12%)
Enrolled Nurse (12 hours)
$2900
$2600(-10%)
Health Assistant (12 hours)
$1600
$1200 (-25%)
Transparent fees
Free choice of medical care candidates
Communicate directly with healthcare providers
Single service charge
Credit Card/Apple Pay
Pregnant women should use caution when using PORACTANT ALFA. This medication is used to treat respiratory distress syndrome in premature infants, and there are some precautions to follow. Pregnant women should tell their doctor if they are pregnant or plan to become pregnant before using this medication. Doctors need to evaluate the benefits and risks to ensure that the effects of the drug on the mother and fetus are minimized.
For pregnant women, when using PORACTANT ALFA, you must closely follow your doctor's instructions and use the drug in the correct dosage and frequency. Pregnant women should inform their doctor immediately if they experience any adverse reactions or symptoms. In addition, pregnant women should avoid using other medications while taking this medication unless approved by their doctor.
In short, the use of PORACTANT ALFA during pregnancy needs to be handled with caution. Pregnant women should keep in close contact with their doctors throughout the process and use the medicine according to the doctor's instructions to ensure the health of mother and child.
No longer restricted by traditional medical care intermediaries, doctors, nurses and customers also have the right to choose! You can also make remote reservations via mobile phone when you are away from home, no need to call to make reservations for family members!
©2024 All Rights Reserved. Created with LOVE and coffee in 🇭🇰